Cargando…

Advanced Glycation End Products: New Clinical and Molecular Perspectives

Diabetes mellitus (DM) is considered one of the most massive epidemics of the twenty-first century due to its high mortality rates caused mainly due to its complications; therefore, the early identification of such complications becomes a race against time to establish a prompt diagnosis. The resear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salazar, Juan, Navarro, Carla, Ortega, Ángel, Nava, Manuel, Morillo, Daniela, Torres, Wheeler, Hernández, Marlon, Cabrera, Mayela, Angarita, Lissé, Ortiz, Rina, Chacín, Maricarmen, D’Marco, Luis, Bermúdez, Valmore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306599/ https://www.ncbi.nlm.nih.gov/pubmed/34299683 http://dx.doi.org/10.3390/ijerph18147236

Ejemplares similares

The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
por: Martínez, María Sofía, et al.
Publicado: (2021)

Microbiota and Diabetes Mellitus: Role of Lipid Mediators
por: Salazar, Juan, et al.
Publicado: (2020)

Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
por: Bermúdez, Valmore, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Metabolic Syndrome: Is It Time to Add the Central Nervous System?
por: Rojas, Milagros, et al.
Publicado: (2021)

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
por: Navarro, Carla, et al.
Publicado: (2022)

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
por: Checa-Ros, Ana, et al.
Publicado: (2023)

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022)

Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
por: Bermúdez, Valmore, et al.
Publicado: (2018)

Sensitivity and Specificity Improvement in Abdominal Obesity Diagnosis Using Cluster Analysis during Waist Circumference Cut-Off Point Selection
por: Bermúdez, Valmore, et al.
Publicado: (2015)

Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
por: Cano, Raquel, et al.
Publicado: (2021)

The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
por: Bermúdez, Valmore, et al.
Publicado: (2021)

Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?
por: Salazar, Juan, et al.
Publicado: (2020)

SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
por: D'Marco, Luis, et al.
Publicado: (2021)

Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population
por: Bermúdez, Valmore, et al.
Publicado: (2014)

Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela
por: Bermudez, Valmore, et al.
Publicado: (2019)

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
por: D’Marco, Luis, et al.
Publicado: (2022)

Intrinsic and environmental basis of aging: A narrative review
por: Navarro, Carla, et al.
Publicado: (2023)

C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation
por: Salazar, Juan, et al.
Publicado: (2014)

Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study
por: Bermúdez, Valmore, et al.
Publicado: (2013)

The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
por: Ortega, Ángel, et al.
Publicado: (2021)

Relationship between Alcohol Consumption and Components of the Metabolic Syndrome in Adult Population from Maracaibo City, Venezuela
por: Bermúdez, Valmore, et al.
Publicado: (2015)

Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age Modulator
por: Salazar, Juan, et al.
Publicado: (2023)

New Evidence on BPA’s Role in Adipose Tissue Development of Proinflammatory Processes and Its Relationship with Obesity
por: González-Casanova, Jorge Enrique, et al.
Publicado: (2023)

Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
por: Chávez-Castillo, Mervin, et al.
Publicado: (2020)

Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2019)

Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
por: Chávez-Castillo, Mervin, et al.
Publicado: (2019)

Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
por: Ortega, Ángel, et al.
Publicado: (2022)

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)

Effect of Oral Nutritional Supplements with Sucromalt and Isomaltulose versus Standard Formula on Glycaemic Index, Entero-Insular Axis Peptides and Subjective Appetite in Patients with Type 2 Diabetes: A Randomised Cross-Over Study
por: Dávila, Lisse Angarita, et al.
Publicado: (2019)

Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review
por: Mouanness, Marco, et al.
Publicado: (2022)

Non-albuminuric Diabetic Kidney Disease Phenotype: Beyond Albuminuria
por: D’Marco, Luis, et al.
Publicado: (2022)

Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela
por: Bermudez, Valmore, et al.
Publicado: (2016)

Insulin Withdrawal in Diabetic Kidney Disease: What Are We Waiting for?
por: Morillas, Carlos, et al.
Publicado: (2021)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease
por: D’Marco, Luis, et al.
Publicado: (2020)

D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food
por: Guerrero-Wyss, Marion, et al.
Publicado: (2018)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_no2n763kogsfkghbcddu6h9ln8